M
$ Value
—
Shares
8,013
Price
—
Filed
Jun 2
Insider
Name
GAYNOR RICHARD
Title
—
CIK
0001741284
Roles
Director
Transaction Details
Transaction Date
2025-05-31
Code
M
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
33,008
Footnotes
Each restricted stock unit represents a contingent right to receive one ordinary share. | This award is fully vested in accordance with its terms.
Filing Info
GAYNOR RICHARD's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-17 | ZLAB | ▲ | $33K ★ |
| 2025-06-18 | ZLAB | A | $0 |
| 2025-05-31 | ALKS | M | — |
| 2025-05-31 | ALKS | F | $59K |
| 2025-05-31 | ALKS | M | — |
| 2025-05-21 | ALKS | A | $0 |
| 2025-05-21 | ALKS | A | $0 |
Other Insiders at ALKS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
POPS RICHARD F
Director and CEO, Alkermes plc
|
— | — | 2026-03-02 |
| Lurker Nancy | — | — | 2026-04-11 |
| Cooke Shane | — | $2.1M | 2026-02-02 |
|
Gaffin David Joseph
EVP, CLO, Alkermes, Inc.
|
— | $190K | 2026-04-06 |
|
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
|
— | $892K | 2026-04-01 |
|
Reed Joshua
SVP, Chief Financial Officer
|
— | — | 2026-03-02 |
|
Nichols Christian Todd
SVP, Chief Commercial Officer
|
— | $180K | 2026-03-02 |
|
Jackson Blair Curtis
EVP, Chief Operating Officer
|
— | — | 2026-03-02 |
|
Parisi Samuel Joseph
VP, Finance (Interim PAO)
|
— | $202K | 2026-03-02 |